WASHINGTON — After a federal judge blocked the deal last month, Aetna on Tuesday announced it would no longer pursue a $37 billion merger with Humana. U.S. District Judge John Bates ruled last month that a merger of the health insurers would result in a lack of competition in the Medicare Advantage market.
WASHINGTON — The antitrust trial over a proposed merger between Aetna and Humana wrapped up Wednesday, with U.S. District Court Judge John Bates asking probing questions of both Justice Department lawyers seeking to block the deal and attorneys for the insurers defending their plan.
Updated at 4:57 p.m.
WASHINGTON — Opening salvos were fired Monday in the antitrust case against the proposed merger of Aetna and Humana, with Justice Department attorneys arguing the tie-up would mean sharp price hikes for Medicare Advantage plans and a disintegration of choice for people purchasing insurance on Affordable Care Act exchanges.
WASHINGTON – As the first part of the antitrust trial on a proposed merger of Anthem and Cigna is wrapping up, a similar challenge to Aetna’s plan to merge with Humana will begin Monday. While both are the result of lawsuits to block the mergers filed by the Justice Department on the same day in July, the trials will be much different.
WASHINGTON — Aetna and Humana said Tuesday they have an agreement to sell Medicare Advantage business covering 290,000 people to rival insurer Molina if their planned merger is allowed to be completed. Aetna also said it is halting 2017 plans to expand participation on public exchanges and is reviewing all of its current participation on Affordable Care Act exchanges.